Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Platform Trials, CCTG Cancer Trials

Lesley Seymour

MD

🏢Queen's University / Canadian Cancer Trials Group🌐Canada

Professor

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Lesley Seymour at CCTG has contributed to cancer clinical trial methodology, including to the development and validation of RECIST (Response Evaluation Criteria in Solid Tumors) — the standardized criteria used globally to assess tumor response in cancer trials. RECIST provides a common language for evaluating treatment responses and has been foundational for regulatory approval of cancer drugs worldwide.

Share:

🧪Research Fields 研究领域

CCTG Canadian cancer clinical trials
platform trial oncology
cancer trial network cooperative
RECIST response criteria
phase II cancer trial design

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Lesley Seymour 的研究动态

Follow Lesley Seymour's research updates

留下邮箱,当我们发布与 Lesley Seymour(Queen's University / Canadian Cancer Trials Group)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment